Voyageur Pharmaceuticals Ltd V.VM

Alternate Symbol(s): VYYRF

Healthcare Drug Manufacturers - Specialty & Generic

Voyageur Pharmaceuticals Ltd. is a Canada-based company engaged in the development of barium and iodine Active Pharmaceutical Ingredients (API) and offers high-performance imaging contrast agents. The Company is focused on vertically integrating the barium and iodine contrast market, and aims at producing its own barium, iodine, and endo fullerenes. The Company’s products include SmoothX, SmoothHD, SmoothLD, VisionHD, VisionLD and V-Gas. SmoothX (2%w/v) is a contrast medium for use in computed tomography (CT) of the gastrointestinal tract. VisionHD is a high-density (98% w/w) barium powder suspension tailored for double-contrast radiographic examination of the gastrointestinal tract, esophagus, stomach and duodenum. It also owns a 100% interest in the Frances Creek barium sulfate (barite) project, which is a rare grade mineral suitable for the pharmaceutical marketplace that is intended to replace the current synthetic products with quality imaging products.

TSXV:VM - Post by User

Voyageur Pharmaceuticals Ltd

<< Previous

Bullboard Posts

Next >>

Post by sdhakaon Jun 04, 2024 2:29pm

140 Views

Post# 36071676

Voyageur Pharmaceuticals Lands Sales Contract for....

Voyageur Pharmaceuticals Lands Sales Contract for Barium Contrast

Voyageur Pharmaceuticals Ltd. (VM) secured a US$1.9 million sales contract for its SmoothX 2% barium contrast product. This is a positive development for VM, representing their first major sales agreement.

The contract is with a Latin American distributor specializing in radiology products. The distributor will be responsible for obtaining regulatory approvals and commercializing the product in their territory.

*FRC provides issuer-paid coverage.

*Past performance is not indicative of future results.

<< Previous

Bullboard Posts

Next >>

E3 inches closer to Alberta's first lithium production plant